Hangzhou Jiuyuan Gene (2566) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Hangzhou Jiuyuan Gene stock HK$9.90, price HK$4.26, upside +132.4%, quality 60 out of 100. Rating: strongly undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Hangzhou Jiuyuan Gene
2566 · HKCheap (57% below fair value) and solid company, but falling price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
23‑month range HK$4.26 – HK$15.62 · fair‑value band HK$7.73 – HK$11.96 · the HK$4.26 price screens below the HK$9.90 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether Hangzhou Jiuyuan Gene is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally.
Show moreShow less
The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting, a palonosetron hydrochloride injection; Jifuwei, a fulvestrant injection; Jitansu, a fosaprepitant dimeglumine injection; and Jixinfen, PEG-G"CSF injection.
It also provides Jilixin avatrombopag maleate tablets; Jipailin, a low molecular weight heparin sodium injection; and Yinuojia, an enoxaparin sodium injection.
The company was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. and changed its name to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. in April 2025. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. was incorporated in 1993 and is headquartered in Hangzhou, China.
Stock analysis
Hangzhou Jiuyuan Gene (2566) currently trades at HK$4.26, while our model-based Fair Value estimate is HK$9.90, implying the stock looks roughly 57% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of HK$14.04 per share, and 22 of the 24 models we run sit above the HK$4.26 price.
Bear case: the Asset-Based group reads lowest at HK$5.02, and 2 of the 24 models stay below the price. Data coverage for this calculation is low.
Scenario range: HK$7.73 (bear) to HK$11.96 (bull), the price of HK$4.26 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Hangzhou Jiuyuan Gene reported revenue of 1.3B CNY in FY2025 versus 1.3B CNY in FY2021, a compound 0.0%/yr. Reported net income was 138M CNY in FY2025, compounding +3.8%/yr from FY2021.
Key figures
Market cap HK$1.0B (≈ $133M) Micro · P/E ratio 8.2 · P/S ratio 0.87 · Dividend yield 1.6% · Net margin 10.6% · Return on equity 8.5% · Return on assets (EBIT) 8.9% (5-year average) · Operating margin 16.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 59% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at 132%, 2566 screens cheaper than that median.
Fair Value models
All 24 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch 2566, get fair value alerts →
Compare Hangzhou Jiuyuan Gene with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 850 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- Stock screener with 62 metrics
- Undervalued stocks: Hong Kong Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $955.47 | $1,275 | +33% | vs 2566 |
| Genmab A/S GMAB | kr 3,448 | kr 3,917 | +14% | vs 2566 |
| Vertex Pharmaceuticals Incorporated VRTX | $538.60 | $592.46 | +10% | vs 2566 |
| Samsung Biologics Co 207940 | 1,411,000 KRW | 1,552,100 KRW | +10% | vs 2566 |
| argenx SE ARGX | $960.04 | $908.40 | −5% | vs 2566 |
| CSL Limited CSL | A$202.92 | A$185.51 | −9% | vs 2566 |
| Moderna, Inc MRNA | $223.37 | $139.99 | −37% | vs 2566 |
| Roivant Sciences Ltd ROIV | $39.53 | $19.47 | −51% | vs 2566 |
| Celltrion, Inc 068270 | 214,000 KRW | 74,945 KRW | −65% | vs 2566 |
| Royalty Pharma plc RPRX | $69.31 | $19.01 | −73% | vs 2566 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Hangzhou Jiuyuan Gene (2566) overvalued or undervalued?
What is the fair value of 2566?
What is the quality score of 2566?
What is the price target for Hangzhou Jiuyuan Gene (2566)?
What is the Hangzhou Jiuyuan Gene stock forecast for 2026?
What is the revenue of Hangzhou Jiuyuan Gene (2566)?
Does Hangzhou Jiuyuan Gene pay a dividend?
How much is the dividend of Hangzhou Jiuyuan Gene (2566) and when is the ex-dividend date?
What growth is priced into Hangzhou Jiuyuan Gene (2566)?
What discount rate (WACC) does the fair value of 2566 use?
What is a reverse DCF?
How much growth has Hangzhou Jiuyuan Gene (2566) delivered so far?
How fast is the sector of Hangzhou Jiuyuan Gene (2566) growing?
What is the free cash flow yield of Hangzhou Jiuyuan Gene (2566)?
What is the intrinsic value of Hangzhou Jiuyuan Gene (2566)?
Is Hangzhou Jiuyuan Gene stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 2566?
How much is Hangzhou Jiuyuan Gene worth?
What do the bullish and bearish scenarios say about 2566?
What is the P/E ratio of 2566?
How solid is the balance sheet of Hangzhou Jiuyuan Gene (2566)?
How far is 2566 from its 52-week high?
Which stocks are comparable to Hangzhou Jiuyuan Gene?
Is Hangzhou Jiuyuan Gene stock attractive at the current price?
How is the fair value of 2566 calculated?
Is it still worth investing in stocks now?
What is the share price of Hangzhou Jiuyuan Gene (2566)?
What should I pay attention to with Hangzhou Jiuyuan Gene right now?
Key figures of Hangzhou Jiuyuan Gene
How large is the market capitalisation of Hangzhou Jiuyuan Gene (2566)?
What is the P/S ratio of Hangzhou Jiuyuan Gene (2566)?
What is the dividend yield of Hangzhou Jiuyuan Gene (2566)?
What is the net margin of Hangzhou Jiuyuan Gene (2566)?
What is the return on equity of Hangzhou Jiuyuan Gene (2566)?
What is the EBIT return on assets of Hangzhou Jiuyuan Gene (2566)?
What is the operating margin of Hangzhou Jiuyuan Gene (2566)?
How fast is revenue growing at Hangzhou Jiuyuan Gene (2566)?
How fast are earnings growing at Hangzhou Jiuyuan Gene (2566)?
How much net debt does Hangzhou Jiuyuan Gene (2566) carry?
Watch Hangzhou Jiuyuan Gene in the live analysis
One click puts Hangzhou Jiuyuan Gene on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.